Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Regulatory News (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.30
Bid: 1.20
Ask: 1.40
Change: -0.20 (-13.33%)
Spread: 0.20 (16.667%)
Open: 1.25
High: 1.30
Low: 1.05
Prev. Close: 1.50
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Dealing

12 Aug 2020 07:00

RNS Number : 8427V
Physiomics PLC
12 August 2020
 

12 August 2020

Physiomics plc

("Physiomics") or ("the Company")

 

Director Dealing

 

The Company announces that it received notice today that Dr Jim Millen sold 597,332 ordinary shares in the Company at 6.45p per share to cover the cost of his exercise of options announced on 5 August 2020.

 

Following the sale of shares, the total holdings of Dr Jim Millen will be 1,386,947, representing approximately 1.42 per cent. of the Company's issued share capital.

 

 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.

 

 

Enquiries:

 

Physiomics plc

Dr Jim Millen, CEO

+44 (0)1865 784 980

 

Hybridan LLP (broker)

Claire Louise Noyce

+44 (0) 203 764 2341

 

Strand Hanson Ltd (NOMAD)

Richard Tulloch & James Dance

+44 (0)20 7409 3494

 

 

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

James Millen

2

Reason for the notification

a)

Position/status

Director, CEO

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Physiomics plc

b)

LEI

213800A71DSZ6ABMTQ91

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares

 

 

 

GB00BDR6W943

b)

Nature of the transaction

Disposal of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

6.45p

597,332

d)

Aggregated information

- Aggregated volume

- Price

 

597,332

At 6.45p per share

e)

Date of the transaction

11-8-2020

f)

Place of the transaction

XLON, AIM

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHPBMRTMTJBBFM
Date   Source Headline
20th Apr 20097:00 amRNSSeminar Presentation
2nd Apr 20097:00 amRNSLicense Agreement with Eli Lilly
1st Apr 20097:00 amRNSChange of Adviser
20th Mar 200912:33 pmRNSHolding(s) in Company
5th Mar 20093:20 pmRNSHolding(s) in Company
10th Feb 20097:30 amRNSHalf Yearly Report
26th Jan 200911:30 amRNSHolding(s) in Company
5th Jan 200910:45 amRNSHolding(s) in Company
19th Dec 200810:58 amRNSResult of AGM
19th Dec 200810:46 amRNSHolding(s) in Company
12th Dec 20087:30 amRNSPlacing of Shares
27th Nov 20087:00 amRNSFinal Results
17th Nov 20087:00 amRNSPhysiomics presentation at Bio-Europe Conference
20th Aug 20087:00 amRNSPhysiomics ICSB presentation
28th Jul 20087:30 amRNSTrading Statement
14th Jul 20087:30 amRNSFurther Agreement with Eli Li
20th Jun 20083:53 pmRNSHolding(s) in Company
3rd Jun 20087:00 amRNSChronotherapy Presentation
20th May 20087:00 amRNSTempo Project Update
22nd Apr 20089:24 amRNSHolding(s) in Company
8th Apr 20087:01 amRNSAACR Presentation Update
31st Mar 20087:00 amRNSInterim Results
15th Feb 200811:33 amRNSRelated party loan
14th Feb 20087:00 amRNSManagement Appointment
13th Feb 200812:07 pmRNSPhysiomics AACR Presentation
21st Dec 200712:37 pmRNSResult of AGM
20th Dec 200711:15 amRNSBoard Changes
17th Dec 20077:00 amRNSMOU with Swansea University
12th Dec 200711:08 amRNSCollaboration Update
30th Nov 20071:54 pmRNSHolding(s) in Company
28th Nov 20077:00 amRNSFinal Results - Replacement
27th Nov 200710:33 amRNSFinal Results
24th Sep 20073:59 pmRNSHolding(s) in Company
17th Sep 20075:25 pmRNSHolding(s) in Company
17th Sep 200711:38 amRNSHolding(s) in Company
17th Sep 20079:00 amRNSCollaboration with Eli Lilly
16th Aug 20077:01 amRNSAIM rule 26 information
13th Aug 20072:35 pmRNSHolding(s) in Company
7th Aug 20074:28 pmRNSHolding(s) in Company
18th May 20074:04 pmRNSDirectorate Change
16th Mar 200711:15 amRNSInterim Results
15th Feb 20077:00 amPRNPhysiomics plc - Agreement
2nd Jan 20077:00 amRNSResult of AGM
19th Dec 20061:01 pmRNSTotal Voting Rights
7th Dec 20062:54 pmRNSNotice of AGM and prelims
7th Nov 20064:47 pmRNSHolding(s) in Company
29th Sep 20062:46 pmRNSAdditional Listing
5th Sep 20062:41 pmPRNNotice of EGM
8th Jun 200610:03 amPRNDirectorate Change
28th Apr 20067:00 amPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.